It is currently Tue Sep 02, 2014 2:57 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Daughter's "treatment"

Have never seen anything on these boards about a doctor in the Netherlands who treats diseases with natural supplements. LONG story short...a mother at my daughter's dance school had a 17 year old son disagnosed with Hodgin's Disease. After tons of chemo and a stem cell transplant, the disease was raging. The young man was given 4 months to live (last year in May). His mother found this doctor in the Netherlands (I had read ...
Read more : Daughter's "treatment" | Views : 5728 | Replies : 17 | Forum : Natural Approach


multipotent mesenchymal stromal cells

If proven helpful, I hope that multipotent mesenchymal stromal cells can be administered without requiring the full AHSC transplant procedure.



Adult stem cells in the treatment of autoimmune diseases.

Rheumatology (Oxford). 2006 Jun 15;
van Laar JM, Tyndall A.
Department of Rheumatology, Leiden University Medical Center, The Netherlands.

During the past 10 yrs, over 700 patients suffering from severe autoimmune disease (AD) have received an autologous haematopoietic stem cell transplant as treatment of their disorder ...
Read more : multipotent mesenchymal stromal cells | Views : 1276 | Replies : 0 | Forum : Stem Cells


(Others) Thoughts on different MS (RR & SP)

The following link had the following explanation, which i personally hadnt read before, and it made sense to me for the progression from RR to SP. dont know if it is still scientifically valid (if it ever was....)
The authors, Prof Compston and Coles of Cambridge, UK, concluded that axons were withering (transecting) due to a loss of trophic support from oligodendrocytes even in the absence of inflammation. ‘Trophic support’ describes the process whereby oligodendrocytes ...
Read more : (Others) Thoughts on different MS (RR & SP) | Views : 1221 | Replies : 3 | Forum : General Discussion


Change of name

PharmaFrontiers, developer of Tovaxin, has changed its name to Opexa.

http://c.moreover.com/click/here.pl?j560790198&w=464753
Read more : Change of name | Views : 1592 | Replies : 4 | Forum : Drug Pipeline


Measuring re-myelination

If they ever figure out how to encourage re-myelination, they will need ways of measuring it.

Some progress being made on the measuring side:

<shortened url>

Ian
Read more : Measuring re-myelination | Views : 896 | Replies : 0 | Forum : General Discussion


Have decided that this is the best MS forum in existence.

So, decided to stop lurking in the dark, here, and say Hello! :wink:

Diagnosed with MS, two years ago; I have been a most difficult patients for all of the neurologists that I've seen (four total) since I refuse to even try CRABS. Am so glad to be in good company with some on this forum.

Have been treating these autoimmune symptoms with diet, supplements, and various ...
Read more : Have decided that this is the best MS forum in existence. | Views : 1521 | Replies : 6 | Forum : Introductions


LDN compounding and the right places

I have only read through some of the various comments. I just wanted to say (or reiterate) that it is critical that a recommended compounding pharmacy be used because of the extremely low amount of actual Naltrexone in a 3 - 4.5 mg capsule. Basically it is about 16% if I calculated right. The best compounders, such as listed at www.lowdosenaltrexone.org (not ".com"), need to be used mainly because ...
Read more : LDN compounding and the right places | Views : 2050 | Replies : 0 | Forum : Low Dose Naltrexone


mt203

Dignan,

I'm losing track of all these drugs - not sure if this one has been posted before.

Ian

Preclinical studies have produced data which supports the potential of Micromet's investigational human antibody MT203 for the treatment of inflammatory conditions such as rheumatoid arthritis and multiple sclerosis.
The study, published in Molecular Immunology, describes one of the first human antibodies potently neutralizing human GM-CSF.

GM-CSF is a key pro-inflammatory cytokine responsible for the proliferation, activation, ...
Read more : mt203 | Views : 1241 | Replies : 1 | Forum : Drug Pipeline


Embryonic stem cell trials coming

Wow, it looks like there are actually going to be trials, and it's to attempt to repair the central nervous system!



First embryonic stem cell trial on the cards

17 June 2006 - NewScientist.com news service - THE first treatment derived from embryonic stem cells might soon undergo clinical trials. The cells would be used to help repair damaged spinal tissue.

One of the main concerns with embryonic stem cell (ESC) treatments has been the ...
Read more : Embryonic stem cell trials coming | Views : 1411 | Replies : 1 | Forum : Stem Cells


Mechanism regulating new cell production discovered

So much stem cell research going on these days...



New stem-cell findings can help the body to cure itself

Researchers at Karolinska Institutet have identified an important mechanism that regulates how many new cells are produced by each intestinal stem cell. The study is published in the latest issue of the prestigious scientific journal Cell.

"This might eventually help us develop new drugs for things like neurological disorders and anaemia," says Professor Jonas Frisén.

In ...
Read more : Mechanism regulating new cell production discovered | Views : 1240 | Replies : 0 | Forum : Stem Cells


 

Login  •  Register


Statistics

Total posts 219670 • Total topics 22680 • Total members 14296


Contact us | Terms of Service